Liposomal benzoquinazoline thymidylate synthase inhibitor formulations

Details for Australian Patent Application No. 2001275269 (hide)

Owner OSI Pharmaceuticals, Inc.

Inventors Ashvar, Claudine S.; Jensen, Gerard M.; Hu, Ning; Chiang, Su-Ming; Emerson, David L.

Agent Davies Collison Cave

Pub. Number AU-B-2001275269

PCT Pub. Number WO01/95884

Priority 60210592 09.06.00 US

Filing date 6 June 2001

Wipo publication date 24 December 2001

Acceptance publication date 13 July 2006

International Classifications

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

Event Publications

13 July 2006 Application Accepted

  Published as AU-B-2001275269

9 November 2006 Standard Patent Sealed

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001275270-Dynamic selection of images for web pages

2001275268